The oral cavity, lined by a mucous membrane called the oral mucosa, serves as a pathway for administering certain medications. This absorption, often categorized as transmucosal, allows the drug to enter the bloodstream directly through the mucosal tissues. This method offers advantages over traditional oral ingestion by bypassing the digestive system and the liver's first-pass metabolism. The two main routes for absorption through the mouth are sublingual (under the tongue) and buccal (between the cheek and gum).
Sublingual Administration
This method involves placing medication under the tongue, where a rich network of capillaries facilitates rapid absorption into the systemic circulation. Examples include nitroglycerin for angina, buprenorphine for opioid dependence, and some vitamin B12 formulations.
Advantages:
- Rapid onset of action
- Avoids first-pass metabolism
- Convenient for patients with swallowing difficulties
Buccal Administration
Medication placed between the gums and inner cheek uses the buccal mucosa for absorption. While generally slower than sublingual, this route can provide a more sustained release. Examples include fentanyl for breakthrough cancer pain, prochlorperazine for nausea and vomiting, and some testosterone treatments.
Advantages:
- Potential for sustained release
- Bypasses first-pass metabolism
- Can be easily removed if needed
The Science Behind Oral Mucosal Absorption
Drug absorption through the oral mucosa primarily relies on passive diffusion. The oral cavity's vascular supply, particularly in the sublingual area, provides an efficient route to the bloodstream. For more detailed information on the factors influencing this process, benefits, limitations, and a comparison of sublingual vs. buccal administration, please refer to {Link: ScienceDirect https://www.sciencedirect.com/science/article/abs/pii/S0168365909005422}.
Conclusion
Yes, drugs can be absorbed through the mouth using sublingual and buccal methods. These routes utilize the oral mucosa's characteristics to provide rapid onset and high bioavailability for specific medications while bypassing the liver. While there are limitations on the dose size, this method is a valuable alternative, especially for patients who cannot swallow and when immediate effects are needed. Ongoing developments in drug formulation are expanding the use of oral transmucosal delivery.